person · Reporting owner

Thorpe Allen R

Disclosed activity across 2 companies

Tapewire entity: 132660
SEC CIK: 0001405076

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Claritev CorpMPLN · Entity 5238	Director	December 04, 2020	December 08, 2020

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Claritev Corp

Report date December 04, 2020 · Filed December 08, 2020

Jointly reported with H&F Corporate Investors VIII, Ltd., Hellman & Friedman Investors VIII, L.P., HFCP VIII (Parallel - A), L.P., Music Investments, L.P., Music Investments GP, LLC

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A common stockSEC Table I · non-derivative	IndirectSee Footnotes	114,721	Reported balance After 2020-12-04 transaction · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · 2020-12-04 · Purchase · Acquired 114,721 · Balance 114,721 F1: Represents shares of Class A common stock purchased in multiple transactions at prices ranging from $7.465 to $7.70. The price reported is a weighted average price. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Class A common stock purchased at each separate price within the range set forth in this footnote (1). F3: Reflects securities directly held by Music Investments, L.P., the general partner of which is Music Investments GP, LLC, the managing member of which is HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A"). F10: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. Allen R. Thorpe, a member of the board of directors of MultiPlan Corporation is a member of the board of directors of H&F VIII.
Class A common stockSEC Table I · non-derivative	IndirectSee Footnotes	1,712,045	Reported balance After 2020-12-07 transaction · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · 2020-12-07 · Purchase · Acquired 1,597,324 · Balance 1,712,045 F2: Represents shares of Class A common stock purchased in multiple transactions at prices ranging from $8.12 to $8.66. The price reported is a weighted average price. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Class A common stock purchased at each separate price within the range set forth in this footnote (2). F3: Reflects securities directly held by Music Investments, L.P., the general partner of which is Music Investments GP, LLC, the managing member of which is HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A"). F10: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. Allen R. Thorpe, a member of the board of directors of MultiPlan Corporation is a member of the board of directors of H&F VIII.
Class A common stockSEC Table I · non-derivative	IndirectSee Footnotes	112,593,413	Reported balance Holding disclosure · report date 2020-12-04 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 112,593,413 F4: Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII"). F10: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. Allen R. Thorpe, a member of the board of directors of MultiPlan Corporation is a member of the board of directors of H&F VIII.
Class A common stockSEC Table I · non-derivative	IndirectSee Footnotes	50,532,114	Reported balance Holding disclosure · report date 2020-12-04 · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · Balance 50,532,114 F5: Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel"). F10: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. Allen R. Thorpe, a member of the board of directors of MultiPlan Corporation is a member of the board of directors of H&F VIII.
Class A common stockSEC Table I · non-derivative	IndirectSee Footnotes	9,549,505	Reported balance Holding disclosure · report date 2020-12-04 · row 5 Holding and transaction disclosures are not merged. 1 source row Row 5 · Balance 9,549,505 F6: Reflects securities directly held by HFCP VIII Parallel-A. F10: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. Allen R. Thorpe, a member of the board of directors of MultiPlan Corporation is a member of the board of directors of H&F VIII.
Class A common stockSEC Table I · non-derivative	IndirectSee Footnotes	2,953,631	Reported balance Holding disclosure · report date 2020-12-04 · row 6 Holding and transaction disclosures are not merged. 1 source row Row 6 · Balance 2,953,631 F7: Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives"). F10: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. Allen R. Thorpe, a member of the board of directors of MultiPlan Corporation is a member of the board of directors of H&F VIII.
Class A common stockSEC Table I · non-derivative	IndirectSee Footnotes	496,709	Reported balance Holding disclosure · report date 2020-12-04 · row 7 Holding and transaction disclosures are not merged. 1 source row Row 7 · Balance 496,709 F8: Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds"). F10: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. Allen R. Thorpe, a member of the board of directors of MultiPlan Corporation is a member of the board of directors of H&F VIII.
Class A common stockSEC Table I · non-derivative	IndirectSee Footnotes	37,677,074	Reported balance Holding disclosure · report date 2020-12-04 · row 8 Holding and transaction disclosures are not merged. 1 source row Row 8 · Balance 37,677,074 F9: Reflects securities directly held by H&F Polaris Partners, L.P. ("Polaris Partners"), the general partner of which is H&F Polaris Partners GP, LLC, the managing member of which is HFCP VIII. F10: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. Allen R. Thorpe, a member of the board of directors of MultiPlan Corporation is a member of the board of directors of H&F VIII.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares of Class A common stock purchased in multiple transactions at prices ranging from $7.465 to $7.70. The price reported is a weighted average price. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Class A common stock purchased at each separate price within the range set forth in this footnote (1).

F2: Represents shares of Class A common stock purchased in multiple transactions at prices ranging from $8.12 to $8.66. The price reported is a weighted average price. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Class A common stock purchased at each separate price within the range set forth in this footnote (2).

F3: Reflects securities directly held by Music Investments, L.P., the general partner of which is Music Investments GP, LLC, the managing member of which is HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A").

F4: Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII").

F5: Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel").

F6: Reflects securities directly held by HFCP VIII Parallel-A.

F7: Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives").

F8: Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds").

F9: Reflects securities directly held by H&F Polaris Partners, L.P. ("Polaris Partners"), the general partner of which is H&F Polaris Partners GP, LLC, the managing member of which is HFCP VIII.

F10: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. Allen R. Thorpe, a member of the board of directors of MultiPlan Corporation is a member of the board of directors of H&F VIII.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

PPD, Inc.

Report date December 08, 2021 · Filed December 08, 2021

Jointly reported with H&F Corporate Investors VII, Ltd., Hellman & Friedman Investors VII, L.P., HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P., HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P., HFCP VII (PARALLEL-A), L.P., H&F EXECUTIVES VII, L.P.

Section 16 reporting ended · disclosed 2021-12-08. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	Reported balance After 2021-12-08 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2021-12-08 · Sale · Disposed 52,884,036 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F2: Reflects securities directly held by Hellman & Friedman Capital Partners VII, L.P. ("HFCP VII"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII.
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	Reported balance After 2021-12-08 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2021-12-08 · Sale · Disposed 20,244,387 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F3: Reflects securities directly held by Hellman & Friedman Capital Partners VII (Parallel), L.P. ("HFCP VII Parallel"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII.
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	Reported balance After 2021-12-08 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 3 · 2021-12-08 · Sale · Disposed 3,630,740 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F4: Reflects securities directly held by HFCP VII (Parallel-A), L.P. ("HFCP VII Parallel-A"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII.
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	Reported balance After 2021-12-08 transaction · row 4 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 4 · 2021-12-08 · Sale · Disposed 359,372 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F5: Reflects securities directly held by H&F Executives VII, L.P. ("H&F VII Executives", and together with HFCP VII, HFCP VII Parallel and HFCP VII Parallel-A, the "H&F VII Funds"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII.
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	Reported balance After 2021-12-08 transaction · row 5 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 5 · 2021-12-08 · Sale · Disposed 35,622,429 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F6: Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII.
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	Reported balance After 2021-12-08 transaction · row 6 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 6 · 2021-12-08 · Sale · Disposed 15,987,409 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F7: Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII.
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	Reported balance After 2021-12-08 transaction · row 7 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 7 · 2021-12-08 · Sale · Disposed 3,021,286 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F8: Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII.
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	Reported balance After 2021-12-08 transaction · row 8 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 8 · 2021-12-08 · Sale · Disposed 934,469 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F9: Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII.
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	Reported balance After 2021-12-08 transaction · row 9 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 9 · 2021-12-08 · Sale · Disposed 157,138 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F10: Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII.

Filing footnotes · ownership attribution and instrument terms

F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash.

F2: Reflects securities directly held by Hellman & Friedman Capital Partners VII, L.P. ("HFCP VII").

F3: Reflects securities directly held by Hellman & Friedman Capital Partners VII (Parallel), L.P. ("HFCP VII Parallel").

F4: Reflects securities directly held by HFCP VII (Parallel-A), L.P. ("HFCP VII Parallel-A").

F5: Reflects securities directly held by H&F Executives VII, L.P. ("H&F VII Executives", and together with HFCP VII, HFCP VII Parallel and HFCP VII Parallel-A, the "H&F VII Funds").

F6: Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII").

F7: Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel").

F8: Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A").

F9: Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives").

F10: Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds").

F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
December 08, 2021 Filed Dec 8, 2021 16:53 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	157,138	$47.50	$7,464,055.00	Disclosure SEC source: 0000899243-21-047342 · doc4.xml · nonDerivative · entry 9 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F10 · ownership.nature: Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
December 08, 2021 Filed Dec 8, 2021 16:53 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	934,469	$47.50	$44,387,277.50	Disclosure SEC source: 0000899243-21-047342 · doc4.xml · nonDerivative · entry 8 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F9 · ownership.nature: Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
December 08, 2021 Filed Dec 8, 2021 16:53 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	3,021,286	$47.50	$143,511,085.00	Disclosure SEC source: 0000899243-21-047342 · doc4.xml · nonDerivative · entry 7 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F8 · ownership.nature: Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
December 08, 2021 Filed Dec 8, 2021 16:53 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	15,987,409	$47.50	$759,401,927.50	Disclosure SEC source: 0000899243-21-047342 · doc4.xml · nonDerivative · entry 6 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F7 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
December 08, 2021 Filed Dec 8, 2021 16:53 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	35,622,429	$47.50	$1,692,065,377.50	Disclosure SEC source: 0000899243-21-047342 · doc4.xml · nonDerivative · entry 5 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F6 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
December 08, 2021 Filed Dec 8, 2021 16:53 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	359,372	$47.50	$17,070,170.00	Disclosure SEC source: 0000899243-21-047342 · doc4.xml · nonDerivative · entry 4 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F5 · ownership.nature: Reflects securities directly held by H&F Executives VII, L.P. ("H&F VII Executives", and together with HFCP VII, HFCP VII Parallel and HFCP VII Parallel-A, the "H&F VII Funds"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
December 08, 2021 Filed Dec 8, 2021 16:53 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	3,630,740	$47.50	$172,460,150.00	Disclosure SEC source: 0000899243-21-047342 · doc4.xml · nonDerivative · entry 3 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F4 · ownership.nature: Reflects securities directly held by HFCP VII (Parallel-A), L.P. ("HFCP VII Parallel-A"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
December 08, 2021 Filed Dec 8, 2021 16:53 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	20,244,387	$47.50	$961,608,382.50	Disclosure SEC source: 0000899243-21-047342 · doc4.xml · nonDerivative · entry 2 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F3 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VII (Parallel), L.P. ("HFCP VII Parallel"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
December 08, 2021 Filed Dec 8, 2021 16:53 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	52,884,036	$47.50	$2,511,991,710.00	Disclosure SEC source: 0000899243-21-047342 · doc4.xml · nonDerivative · entry 1 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F2 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VII, L.P. ("HFCP VII"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
December 07, 2020 Filed Dec 8, 2020 11:06 UTC	Claritev Corp MPLN · Entity 5238	PurchaseClass A common stock	1,597,324	$8.34	$13,329,029.85	Disclosure SEC source: 0000899243-20-032967 · doc4.xml · nonDerivative · entry 2 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner Music Investments, L.P. · CIK 0001834598 · 10% owner Music Investments GP, LLC · CIK 0001834610 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,712,045 F2 · price: Represents shares of Class A common stock purchased in multiple transactions at prices ranging from $8.12 to $8.66. The price reported is a weighted average price. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Class A common stock purchased at each separate price within the range set forth in this footnote (2). F3 · ownership.nature: Reflects securities directly held by Music Investments, L.P., the general partner of which is Music Investments GP, LLC, the managing member of which is HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A"). F10 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. Allen R. Thorpe, a member of the board of directors of MultiPlan Corporation is a member of the board of directors of H&F VIII. Read SEC document
December 04, 2020 Filed Dec 8, 2020 11:06 UTC	Claritev Corp MPLN · Entity 5238	PurchaseClass A common stock	114,721	$7.54	$864,571.87	Disclosure SEC source: 0000899243-20-032967 · doc4.xml · nonDerivative · entry 1 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner Music Investments, L.P. · CIK 0001834598 · 10% owner Music Investments GP, LLC · CIK 0001834610 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 114,721 F1 · price: Represents shares of Class A common stock purchased in multiple transactions at prices ranging from $7.465 to $7.70. The price reported is a weighted average price. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Class A common stock purchased at each separate price within the range set forth in this footnote (1). F3 · ownership.nature: Reflects securities directly held by Music Investments, L.P., the general partner of which is Music Investments GP, LLC, the managing member of which is HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A"). F10 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. Allen R. Thorpe, a member of the board of directors of MultiPlan Corporation is a member of the board of directors of H&F VIII. Read SEC document
October 08, 2020 Filed Oct 13, 2020 17:33 UTC	Claritev Corp MPLN · Entity 5238	GrantClass A common stock	37,677,074	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-028052 · doc4.xml · nonDerivative · entry 6 Thorpe Allen R · CIK 0001405076 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 37,677,074 F1 · kind: Reflects shares of Class A common stock of the Issuer ("Common Stock") received pursuant to an Agreement and Plan of Merger, dated July 12, 2020 (the "Merger Agreement"), by and among the Issuer (formerly known as Churchill Capital Corp III), Polaris Parent Corp. ("MultiPlan Parent"), Polaris Investment Holdings, L.P., Music Merger Sub I, Inc. and Music Merger Sub II LLC, pursuant to which Music Merger Sub I, Inc. merged with MultiPlan Parent, with MultiPlan Parent surviving, and MultiPlan Parent merged with and into Music Merger Sub II LLC, with Music Merger Sub II LLC surviving the merger as a wholly owned subsidiary of the Issuer (which changed its name to MultiPlan Corporation). Pursuant to the Merger Agreement, former stockholders of MultiPlan Parent received their pro rata portion of the merger consideration, which was equal to $5,678,000,000, paid in a combination of $1,521,000,000 cash with the remainder paid in shares of Common Stock in an amount equal to $10.00 per share. F1 · price: Reflects shares of Class A common stock of the Issuer ("Common Stock") received pursuant to an Agreement and Plan of Merger, dated July 12, 2020 (the "Merger Agreement"), by and among the Issuer (formerly known as Churchill Capital Corp III), Polaris Parent Corp. ("MultiPlan Parent"), Polaris Investment Holdings, L.P., Music Merger Sub I, Inc. and Music Merger Sub II LLC, pursuant to which Music Merger Sub I, Inc. merged with MultiPlan Parent, with MultiPlan Parent surviving, and MultiPlan Parent merged with and into Music Merger Sub II LLC, with Music Merger Sub II LLC surviving the merger as a wholly owned subsidiary of the Issuer (which changed its name to MultiPlan Corporation). Pursuant to the Merger Agreement, former stockholders of MultiPlan Parent received their pro rata portion of the merger consideration, which was equal to $5,678,000,000, paid in a combination of $1,521,000,000 cash with the remainder paid in shares of Common Stock in an amount equal to $10.00 per share. F7 · ownership.nature: Reflects securities directly held by H&F Polaris Partners, L.P. ("Polaris Partners"), the general partner of which is H&F Polaris Partners GP, LLC, the managing member of which is HFCP VIII. F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. Allen R. Thorpe, a member of the board of directors ofMultiPlan Corporation is a member of the board of directors of H&F VIII. Read SEC document
October 08, 2020 Filed Oct 13, 2020 17:33 UTC	Claritev Corp MPLN · Entity 5238	GrantClass A common stock	496,709	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-028052 · doc4.xml · nonDerivative · entry 5 Thorpe Allen R · CIK 0001405076 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 496,709 F1 · kind: Reflects shares of Class A common stock of the Issuer ("Common Stock") received pursuant to an Agreement and Plan of Merger, dated July 12, 2020 (the "Merger Agreement"), by and among the Issuer (formerly known as Churchill Capital Corp III), Polaris Parent Corp. ("MultiPlan Parent"), Polaris Investment Holdings, L.P., Music Merger Sub I, Inc. and Music Merger Sub II LLC, pursuant to which Music Merger Sub I, Inc. merged with MultiPlan Parent, with MultiPlan Parent surviving, and MultiPlan Parent merged with and into Music Merger Sub II LLC, with Music Merger Sub II LLC surviving the merger as a wholly owned subsidiary of the Issuer (which changed its name to MultiPlan Corporation). Pursuant to the Merger Agreement, former stockholders of MultiPlan Parent received their pro rata portion of the merger consideration, which was equal to $5,678,000,000, paid in a combination of $1,521,000,000 cash with the remainder paid in shares of Common Stock in an amount equal to $10.00 per share. F1 · price: Reflects shares of Class A common stock of the Issuer ("Common Stock") received pursuant to an Agreement and Plan of Merger, dated July 12, 2020 (the "Merger Agreement"), by and among the Issuer (formerly known as Churchill Capital Corp III), Polaris Parent Corp. ("MultiPlan Parent"), Polaris Investment Holdings, L.P., Music Merger Sub I, Inc. and Music Merger Sub II LLC, pursuant to which Music Merger Sub I, Inc. merged with MultiPlan Parent, with MultiPlan Parent surviving, and MultiPlan Parent merged with and into Music Merger Sub II LLC, with Music Merger Sub II LLC surviving the merger as a wholly owned subsidiary of the Issuer (which changed its name to MultiPlan Corporation). Pursuant to the Merger Agreement, former stockholders of MultiPlan Parent received their pro rata portion of the merger consideration, which was equal to $5,678,000,000, paid in a combination of $1,521,000,000 cash with the remainder paid in shares of Common Stock in an amount equal to $10.00 per share. F6 · ownership.nature: Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds"). F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. Allen R. Thorpe, a member of the board of directors ofMultiPlan Corporation is a member of the board of directors of H&F VIII. Read SEC document
October 08, 2020 Filed Oct 13, 2020 17:33 UTC	Claritev Corp MPLN · Entity 5238	GrantClass A common stock	2,953,631	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-028052 · doc4.xml · nonDerivative · entry 4 Thorpe Allen R · CIK 0001405076 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 2,953,631 F1 · kind: Reflects shares of Class A common stock of the Issuer ("Common Stock") received pursuant to an Agreement and Plan of Merger, dated July 12, 2020 (the "Merger Agreement"), by and among the Issuer (formerly known as Churchill Capital Corp III), Polaris Parent Corp. ("MultiPlan Parent"), Polaris Investment Holdings, L.P., Music Merger Sub I, Inc. and Music Merger Sub II LLC, pursuant to which Music Merger Sub I, Inc. merged with MultiPlan Parent, with MultiPlan Parent surviving, and MultiPlan Parent merged with and into Music Merger Sub II LLC, with Music Merger Sub II LLC surviving the merger as a wholly owned subsidiary of the Issuer (which changed its name to MultiPlan Corporation). Pursuant to the Merger Agreement, former stockholders of MultiPlan Parent received their pro rata portion of the merger consideration, which was equal to $5,678,000,000, paid in a combination of $1,521,000,000 cash with the remainder paid in shares of Common Stock in an amount equal to $10.00 per share. F1 · price: Reflects shares of Class A common stock of the Issuer ("Common Stock") received pursuant to an Agreement and Plan of Merger, dated July 12, 2020 (the "Merger Agreement"), by and among the Issuer (formerly known as Churchill Capital Corp III), Polaris Parent Corp. ("MultiPlan Parent"), Polaris Investment Holdings, L.P., Music Merger Sub I, Inc. and Music Merger Sub II LLC, pursuant to which Music Merger Sub I, Inc. merged with MultiPlan Parent, with MultiPlan Parent surviving, and MultiPlan Parent merged with and into Music Merger Sub II LLC, with Music Merger Sub II LLC surviving the merger as a wholly owned subsidiary of the Issuer (which changed its name to MultiPlan Corporation). Pursuant to the Merger Agreement, former stockholders of MultiPlan Parent received their pro rata portion of the merger consideration, which was equal to $5,678,000,000, paid in a combination of $1,521,000,000 cash with the remainder paid in shares of Common Stock in an amount equal to $10.00 per share. F5 · ownership.nature: Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives"). F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. Allen R. Thorpe, a member of the board of directors ofMultiPlan Corporation is a member of the board of directors of H&F VIII. Read SEC document
October 08, 2020 Filed Oct 13, 2020 17:33 UTC	Claritev Corp MPLN · Entity 5238	GrantClass A common stock	9,549,505	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-028052 · doc4.xml · nonDerivative · entry 3 Thorpe Allen R · CIK 0001405076 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 9,549,505 F1 · kind: Reflects shares of Class A common stock of the Issuer ("Common Stock") received pursuant to an Agreement and Plan of Merger, dated July 12, 2020 (the "Merger Agreement"), by and among the Issuer (formerly known as Churchill Capital Corp III), Polaris Parent Corp. ("MultiPlan Parent"), Polaris Investment Holdings, L.P., Music Merger Sub I, Inc. and Music Merger Sub II LLC, pursuant to which Music Merger Sub I, Inc. merged with MultiPlan Parent, with MultiPlan Parent surviving, and MultiPlan Parent merged with and into Music Merger Sub II LLC, with Music Merger Sub II LLC surviving the merger as a wholly owned subsidiary of the Issuer (which changed its name to MultiPlan Corporation). Pursuant to the Merger Agreement, former stockholders of MultiPlan Parent received their pro rata portion of the merger consideration, which was equal to $5,678,000,000, paid in a combination of $1,521,000,000 cash with the remainder paid in shares of Common Stock in an amount equal to $10.00 per share. F1 · price: Reflects shares of Class A common stock of the Issuer ("Common Stock") received pursuant to an Agreement and Plan of Merger, dated July 12, 2020 (the "Merger Agreement"), by and among the Issuer (formerly known as Churchill Capital Corp III), Polaris Parent Corp. ("MultiPlan Parent"), Polaris Investment Holdings, L.P., Music Merger Sub I, Inc. and Music Merger Sub II LLC, pursuant to which Music Merger Sub I, Inc. merged with MultiPlan Parent, with MultiPlan Parent surviving, and MultiPlan Parent merged with and into Music Merger Sub II LLC, with Music Merger Sub II LLC surviving the merger as a wholly owned subsidiary of the Issuer (which changed its name to MultiPlan Corporation). Pursuant to the Merger Agreement, former stockholders of MultiPlan Parent received their pro rata portion of the merger consideration, which was equal to $5,678,000,000, paid in a combination of $1,521,000,000 cash with the remainder paid in shares of Common Stock in an amount equal to $10.00 per share. F4 · ownership.nature: Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A"). F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. Allen R. Thorpe, a member of the board of directors ofMultiPlan Corporation is a member of the board of directors of H&F VIII. Read SEC document
October 08, 2020 Filed Oct 13, 2020 17:33 UTC	Claritev Corp MPLN · Entity 5238	GrantClass A common stock	50,532,114	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-028052 · doc4.xml · nonDerivative · entry 2 Thorpe Allen R · CIK 0001405076 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 50,532,114 F1 · kind: Reflects shares of Class A common stock of the Issuer ("Common Stock") received pursuant to an Agreement and Plan of Merger, dated July 12, 2020 (the "Merger Agreement"), by and among the Issuer (formerly known as Churchill Capital Corp III), Polaris Parent Corp. ("MultiPlan Parent"), Polaris Investment Holdings, L.P., Music Merger Sub I, Inc. and Music Merger Sub II LLC, pursuant to which Music Merger Sub I, Inc. merged with MultiPlan Parent, with MultiPlan Parent surviving, and MultiPlan Parent merged with and into Music Merger Sub II LLC, with Music Merger Sub II LLC surviving the merger as a wholly owned subsidiary of the Issuer (which changed its name to MultiPlan Corporation). Pursuant to the Merger Agreement, former stockholders of MultiPlan Parent received their pro rata portion of the merger consideration, which was equal to $5,678,000,000, paid in a combination of $1,521,000,000 cash with the remainder paid in shares of Common Stock in an amount equal to $10.00 per share. F1 · price: Reflects shares of Class A common stock of the Issuer ("Common Stock") received pursuant to an Agreement and Plan of Merger, dated July 12, 2020 (the "Merger Agreement"), by and among the Issuer (formerly known as Churchill Capital Corp III), Polaris Parent Corp. ("MultiPlan Parent"), Polaris Investment Holdings, L.P., Music Merger Sub I, Inc. and Music Merger Sub II LLC, pursuant to which Music Merger Sub I, Inc. merged with MultiPlan Parent, with MultiPlan Parent surviving, and MultiPlan Parent merged with and into Music Merger Sub II LLC, with Music Merger Sub II LLC surviving the merger as a wholly owned subsidiary of the Issuer (which changed its name to MultiPlan Corporation). Pursuant to the Merger Agreement, former stockholders of MultiPlan Parent received their pro rata portion of the merger consideration, which was equal to $5,678,000,000, paid in a combination of $1,521,000,000 cash with the remainder paid in shares of Common Stock in an amount equal to $10.00 per share. F3 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel"). F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. Allen R. Thorpe, a member of the board of directors ofMultiPlan Corporation is a member of the board of directors of H&F VIII. Read SEC document
October 08, 2020 Filed Oct 13, 2020 17:33 UTC	Claritev Corp MPLN · Entity 5238	GrantClass A common stock	112,593,413	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-028052 · doc4.xml · nonDerivative · entry 1 Thorpe Allen R · CIK 0001405076 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 112,593,413 F1 · kind: Reflects shares of Class A common stock of the Issuer ("Common Stock") received pursuant to an Agreement and Plan of Merger, dated July 12, 2020 (the "Merger Agreement"), by and among the Issuer (formerly known as Churchill Capital Corp III), Polaris Parent Corp. ("MultiPlan Parent"), Polaris Investment Holdings, L.P., Music Merger Sub I, Inc. and Music Merger Sub II LLC, pursuant to which Music Merger Sub I, Inc. merged with MultiPlan Parent, with MultiPlan Parent surviving, and MultiPlan Parent merged with and into Music Merger Sub II LLC, with Music Merger Sub II LLC surviving the merger as a wholly owned subsidiary of the Issuer (which changed its name to MultiPlan Corporation). Pursuant to the Merger Agreement, former stockholders of MultiPlan Parent received their pro rata portion of the merger consideration, which was equal to $5,678,000,000, paid in a combination of $1,521,000,000 cash with the remainder paid in shares of Common Stock in an amount equal to $10.00 per share. F1 · price: Reflects shares of Class A common stock of the Issuer ("Common Stock") received pursuant to an Agreement and Plan of Merger, dated July 12, 2020 (the "Merger Agreement"), by and among the Issuer (formerly known as Churchill Capital Corp III), Polaris Parent Corp. ("MultiPlan Parent"), Polaris Investment Holdings, L.P., Music Merger Sub I, Inc. and Music Merger Sub II LLC, pursuant to which Music Merger Sub I, Inc. merged with MultiPlan Parent, with MultiPlan Parent surviving, and MultiPlan Parent merged with and into Music Merger Sub II LLC, with Music Merger Sub II LLC surviving the merger as a wholly owned subsidiary of the Issuer (which changed its name to MultiPlan Corporation). Pursuant to the Merger Agreement, former stockholders of MultiPlan Parent received their pro rata portion of the merger consideration, which was equal to $5,678,000,000, paid in a combination of $1,521,000,000 cash with the remainder paid in shares of Common Stock in an amount equal to $10.00 per share. F2 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII"). F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. Allen R. Thorpe, a member of the board of directors ofMultiPlan Corporation is a member of the board of directors of H&F VIII. Read SEC document
September 21, 2020 Filed Sep 23, 2020 16:47 UTC	PPD, Inc. PPD · Entity 15247	GiftCommon Stock	127,867	$0.00	$0.00	Disclosure SEC source: 0000899243-20-026095 · doc4.xml · nonDerivative · entry 11 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F13 · ownership.direct: These shares of Common Stock were received by Mr. Thorpe in connection with pro rata distributions made by HFCP VII described above and were transferred as a charitable donation upon receipt. Read SEC document
September 21, 2020 Filed Sep 23, 2020 16:47 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	30,264	$31.28	$946,733.58	Disclosure SEC source: 0000899243-20-026095 · doc4.xml · nonDerivative · entry 10 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 157,138 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F10 · ownership.nature: Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
September 21, 2020 Filed Sep 23, 2020 16:47 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	179,980	$31.28	$5,630,224.35	Disclosure SEC source: 0000899243-20-026095 · doc4.xml · nonDerivative · entry 9 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 934,469 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F9 · ownership.nature: Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
September 21, 2020 Filed Sep 23, 2020 16:47 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	581,903	$31.28	$18,203,380.60	Disclosure SEC source: 0000899243-20-026095 · doc4.xml · nonDerivative · entry 8 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,021,286 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F8 · ownership.nature: Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
September 21, 2020 Filed Sep 23, 2020 16:47 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	3,079,193	$31.28	$96,324,855.02	Disclosure SEC source: 0000899243-20-026095 · doc4.xml · nonDerivative · entry 7 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 15,987,409 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F7 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
September 21, 2020 Filed Sep 23, 2020 16:47 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	6,860,919	$31.28	$214,626,698.62	Disclosure SEC source: 0000899243-20-026095 · doc4.xml · nonDerivative · entry 6 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 35,622,429 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F6 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
September 21, 2020 Filed Sep 23, 2020 16:47 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	69,215	$31.28	$2,165,218.24	Disclosure SEC source: 0000899243-20-026095 · doc4.xml · nonDerivative · entry 5 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 359,372 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F5 · ownership.nature: Reflects securities directly held by H&F Executives VII, L.P. ("H&F VII Executives", and together with HFCP VII, HFCP VII Parallel and HFCP VII Parallel-A, the "H&F VII Funds"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
September 21, 2020 Filed Sep 23, 2020 16:47 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	699,284	$31.28	$21,875,351.73	Disclosure SEC source: 0000899243-20-026095 · doc4.xml · nonDerivative · entry 4 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,630,740 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F4 · ownership.nature: Reflects securities directly held by HFCP VII (Parallel-A), L.P. ("HFCP VII Parallel-A"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
September 21, 2020 Filed Sep 23, 2020 16:47 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	3,899,092	$31.28	$121,973,345.49	Disclosure SEC source: 0000899243-20-026095 · doc4.xml · nonDerivative · entry 3 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 20,244,387 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F3 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VII (Parallel), L.P. ("HFCP VII Parallel"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
September 21, 2020 Filed Sep 23, 2020 16:47 UTC	PPD, Inc. PPD · Entity 15247	OtherCommon Stock	883,200	$0.00	$0.00	Disclosure SEC source: 0000899243-20-026095 · doc4.xml · nonDerivative · entry 2 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 52,884,036 F12 · kind: Represents in-kind distributions of shares of Common Stock previously held by HFCP VII to certain of its direct and indirect partners for the sole purpose of charitable giving. F2 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VII, L.P. ("HFCP VII"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
September 21, 2020 Filed Sep 23, 2020 16:47 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	9,302,325	$31.28	$290,999,981.81	Disclosure SEC source: 0000899243-20-026095 · doc4.xml · nonDerivative · entry 1 H&F Corporate Investors VII, Ltd. · CIK 0001660963 · 10% owner Hellman & Friedman Investors VII, L.P. · CIK 0001779162 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII, L.P. · CIK 0001458179 · 10% owner HELLMAN & FRIEDMAN CAPITAL PARTNERS VII (PARALLEL), L.P. · CIK 0001458222 · 10% owner HFCP VII (PARALLEL-A), L.P. · CIK 0001458221 · 10% owner H&F EXECUTIVES VII, L.P. · CIK 0001458212 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 53,767,236 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F2 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VII, L.P. ("HFCP VII"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.